New Chair Leads Rehabilitation Medicine Department

Joseph E. Herrera, DO

Joseph E. Herrera, DO

Joseph E. Herrera, DO, was appointed Chair of the Mount Sinai Health System Department of Rehabilitation Medicine in July. The noted clinician, educator, and researcher previously served as Chair of Physical Medicine and Rehabilitation at Mount Sinai Beth Israel, where he introduced innovative therapies and helped build highly selective residency and fellowship programs. Dr. Herrera is also Associate Professor of Rehabilitation
Medicine at the Icahn School of Medicine
at Mount Sinai. (more…)

Studying a New Treatment for Chronic Knee and Back Pain

Steven Venegas, DPT, Senior Physical Therapist, Mount Sinai Beth Israel, calibrates pods on the bottom of specially designed biomechanical shoes for a patient.

Steven Venegas, DPT, Senior Physical Therapist, Mount Sinai Beth Israel, calibrates pods on the bottom of specially designed biomechanical shoes for a patient.

“We are very excited about introducing AposTherapy to treat chronic knee and back pain,” says Joseph E. Herrera, DO, Chair of the Department of Rehabilitation Medicine. Developed in Israel, AposTherapy uses specially designed biomechanical shoes to retrain the muscles around the knee by adjusting the center of pressure when walking. By changing the foot’s point of contact with the ground, the device shifts the line of force closer to the center of the knee. Pods on the bottom of the shoes are calibrated for each patient by a specially trained physical therapist. Patients wear the shoes for up to two hours a day during their regular activities. The AposTherapy treatment  is being offered as part of a study being conducted at Mount Sinai. The study has enrolled 73 patients. To learn more, visit mountsinai.org/apos or email RehabBIappt@chpnet.org.

Dr. Herrera is a non-paid member of the Medical Advisory Board of AposTherapy.

Unique Public-Private Collaboration with Celgene To Accelerate Important Cancer Discoveries

Burakoff_Lium_040.JPG

Left: Erik Lium, PhD, Senior Vice President of Mount Sinai Innovation Partners; and Steven J. Burakoff, MD, Director of The Tisch Cancer Institute at the Icahn School of Medicine

The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai and three other leading U.S. academic institutions recently established a pioneering research consortium to accelerate the discovery of new treatments for cancer.

In addition, Celgene Corp., a global biopharmaceutical company, paid $50 million to enter into four public-private collaboration agreements with each member of the new consortium for the option of developing and commercializing novel cancer therapeutics arising from their efforts. (more…)

Snapshots from Aspen

Aspen-Ideas-Festival- RS26141-RT

Members of the Mount Sinai panel included, from left, Ross L. Cagan, PhD, Director, Center for Personalized Cancer Therapeutics; Matthew Galsky, MD, Director of Genitourinary Medical Oncology; Joshua Brody, MD, Director, Lymphoma Immunotherapy Program; Steven J. Burakoff, MD, Director of The Tisch Cancer Institute; and Kenneth L. Davis, MD, President and Chief Executive Officer, Mount Sinai Health System.

At the 2016 Aspen Ideas Festival, a public gathering dedicated to the global exchange of ideas, faculty and staff from the Mount Sinai Health System provided attendees with complimentary skin cancer and heart health screenings, and participated in panel discussions on topics that included drug prices, living organ donations, gene-editing technologies, and ways to improve health care globally. The festival is presented by the Aspen Institute in partnership with The Atlantic magazine.

In a panel discussion on “Cancer Breakthroughs: The Promise of New Treatments,” specialists from the Mount Sinai Health System discussed significant advances being made in personalized vaccines and immunotherapies. The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai is involved in clinical trials that are exploring multiple approaches to immunotherapy, including intratumoral injections that are being used in combination with traditional treatments, such as surgery, radiation, and chemotherapy. (more…)

Early Skin Cancer Screening Minimizes Complications

Aspen-Ideas-Festival- IMG_3030

Melinda Sacks receives a skin cancer screening from Morgan Rabach, MD, Clinical Instructor, Icahn School of Medicine at Mount Sinai.

When Melinda Sacks joined hundreds of other attendees at the 2014 Aspen Ideas Festival, in Aspen, Colorado, to receive a complimentary skin cancer screening by dermatologists at the Mount Sinai Health System, the clinician told her she had a suspicious spot on her face that should be checked by a specialist as soon as she returned home to Stanford, California.

Ms. Sacks says she was surprised by this because “I thought it was a birth mark.” But the small pigmented spot with a clearly defined edge was a lentigo maligna—an early form of melanoma, in which the malignant cells are confined to the tissue of origin. By catching the disease at an early stage, Ms. Sacks was able to have it removed without further complications. (more…)

Mount Sinai Queens Heralds a New Era of Community Health Care with Opening of Ambulatory Pavilion

Ambulance_038.jpg

From left: Darren Fitzpatrick, MD; Ugo Ezenkwele, MD; Brian Radbill, MD, FACP; and Fernando C. Carnavali, MD, at the Mount Sinai Queens Ambulatory Pavilion

Against a backdrop of an evolving national health care system increasingly focused on preventive medicine, outpatient surgical procedures, and other efforts to keep people healthy and out of the hospital, Mount Sinai Queens has opened the doors to its new Ambulatory Pavilion, a $175 million facility that allows it to better serve the health needs of its community and significantly expands its medical and surgical capabilities.

Mount Sinai Queens is located in the heart of Astoria and serves the communities of Western Queens and beyond. With the addition of the Ambulatory Pavilion and continued expansion, it is positioning itself to care for more patients and extend its geographical reach throughout New York City’s largest borough. (more…)

Pin It on Pinterest